ERIS Lifesciences Ltd Half Yearly Results

Gross Sales

1,454.54

1,030.75

960.55

814.43

847.38

Excise Duty

0

0

0

0

0

Net Sales

1,454.54

1,030.75

960.55

814.43

847.38

Other Operating Income

6.35

6.48

11.37

11.62

11.71

Other Income

6.19

19.35

4.47

3.24

7.91

Total Income

1,467.08

1,056.58

976.39

829.3

867.01

Total Expenditure

946.39

713.29

621.03

569.96

578.44

PBIDT

520.69

343.29

355.36

259.34

288.56

Interest

119.84

51.15

33.65

11.87

14.3

PBDT

400.85

292.14

321.71

247.47

274.26

Depreciation

156.42

99.62

82.99

65.03

52.06

Minority Interest Before NP

0

0

0

0

0

Tax

55.59

35.11

47.11

32.68

41.98

Deferred Tax

3.07

-23.68

-24.35

-11.95

-32.23

Reported Profit After Tax

185.77

181.09

215.96

161.71

212.45

Minority Interest After NP

11

7.39

-2.32

-5.57

-2.43

Net Profit after Minority Interest

174.77

173.7

218.29

167.28

214.88

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

174.77

173.7

218.29

167.28

214.88

EPS (Unit Curr.)

12.84

12.77

16.05

12.3

15.8

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

0

0

735

Equity

13.61

13.6

13.6

13.6

13.6

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

35.79

33.3

36.99

31.84

34.05

PBDTM(%)

-

-

-

-

-

PATM(%)

12.77

17.56

22.48

19.85

25.07